Recommended Pages at empr.com

Latuda Dosing Range Updated #sunovion #antipsychotic #schizophrenia http://t.co/Bkpd52pO

Phase 3 Study of Aripiprazole Intramuscular Depot for the Maintenance Treatment of Schizophrenia - MPR

empr.com — “Otsuka and Lundbeck announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular (IM) depot formulation for the maintenance treatment of adults with schizophrenia.” View full resource at empr.com

Most Recently Shared on May 7, 2012 at 5:18 pm By:

Phase 3 Study of #Aripiprazole Intramuscular Depot for the Maintenance Treatment of #Schizophrenia http://t.co/hAN0om32

FDA Issues Complete Response Letter to NDA for Adasuve - MPR

empr.com — “Alexza Pharmaceuticals announced that it has received a complete response letter from the FDA regarding its New Drug Application (NDA) for Adasuve (Staccato loxapine) inhalation powder, 5mg and 10mg, for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.” View full resource at empr.com

Most Recently Shared on May 7, 2012 at 3:35 pm By:

FDA Issues Complete Response Letter to NDA for #Adasuve #Alexza #loxapine #inhalation #agitation http://t.co/UloQRAV8

Phase 3 Trial Update of Latuda for Bipolar I Depression - MPR

empr.com — “Dainippon Sumitomo Pharma announced results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of Latuda (lurasidone; Sunovion) as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).” View full resource at empr.com

Most Recently Shared on May 7, 2012 at 2:27 pm By:

Phase 3 Trial Update of #Latuda for #Bipolar I #Depression http://t.co/qSy2y0ba

RECALL: Franck's Compounding Triamcinolone Acetonide Recall - MPR

empr.com — “Franck's Compounding Pharmacy has recalled one additional lot of triamcinolone acetonide PF 80mg/mL.” View full resource at empr.com

Most Recently Shared on May 4, 2012 at 7:31 pm By:

#RECALL: Franck's Compounding Triamcinolone Acetonide Recall #ophthalmologist #infection http://t.co/PkKV2YhX

Phase 3 Study Update of 4-Factor Prothrombin Complex Concentrate for Hemostasis - MPR

empr.com — “CSL Behring announced results of a Phase 3b study that showed that a balanced, human 4-factor prothrombin complex concentrate (PCC) is as effective as the current standard of treatment in stopping bleeding in patients receiving vitamin K antagonist therapy (eg, warfarin).” View full resource at empr.com

Most Recently Shared on May 4, 2012 at 6:07 pm By:

Phase 3 Study Update of 4-Factor #Prothrombin Complex Concentrate for #Hemostasis #hematology #bleeding http://t.co/v674R0I1

Phase 3 Study Update of Gattex for Adult Short Bowel Syndrome - MPR

empr.com — “NPS Pharmaceuticals reported that four additional patients have successfully achieved independence from parenteral nutrition (PN) and intravenous (IV) fluids while on long-term Gattex (teduglutide) therapy in STEPS 2, a 24-month open-label study in adult short bowel syndrome (SBS).” View full resource at empr.com

Most Recently Shared on May 3, 2012 at 1:42 pm By:

Phase 3 Study Update of #Gattex for Adult Short Bowel Syndrome #gastrointestinal #teduglutide http://t.co/iSRCodf7

Dymista Approved for Allergic Rhinitis - MPR

empr.com — “Meda announced that the FDA has approved Dymista (azelastine HCl and fluticasone propionate) nasal spray for the treatment of seasonal allergic rhinitis.” View full resource at empr.com

Most Recently Shared on May 2, 2012 at 2:02 pm By:

Dymista Approved for #Allergic Rhinitis #meda #nasal http://t.co/kCeKMvUM

QNASL - New Product Releases - MPR

empr.com — “Seasonal and perennial allergic rhinitis.” View full resource at empr.com

Most Recently Shared on May 2, 2012 at 1:06 pm By:

NEW PRODUCT: Learn more about QNASL for seasonal and perennial allergic rhinitis http://t.co/oo0KDmhl #allergies

Phase 3 Study Update of Quadrivalent Influenza Vaccine in Pediatric Population - MPR

empr.com — “Sanofi Pasteur, the vaccines division of Sanofi Aventis, announced new Phase 3 data for its investigational quadrivalent influenza vaccine (QIV) in children.” View full resource at empr.com

Most Recently Shared on May 1, 2012 at 6:57 pm By:

Phase 3 Study Update of Quadrivalent #Influenza #Vaccine in #Pediatric Population #Sanofi #pediatrician #immunization http://t.co/XI20ORHX

Mylan Launches Generic Doryx 150mg - MPR

empr.com — “Mylan announced the launch of Doxycycline hyclate delayed-release (DR) tablets, 150mg, the generic version of Warner Chilcott's Doryx tablets.” View full resource at empr.com

Most Recently Shared on May 1, 2012 at 2:35 pm By:

#Mylan Launches #Generic Doryx 150mg #antibiotic #acne http://t.co/jzTB1KKP

Gluten Free Bee Patient Expert

AAN: Migraine Prevalence Up in Celiac Disease, IBD Patients - MPR

empr.com — “Patients with celiac disease or inflammatory bowel disease (IBD) and those self-classified with gluten sensitivity (GS) have increased prevalence of migraine.” View full resource at empr.com

Most Recently Shared on April 30, 2012 at 11:07 pm By:

AAN: Migraine Prevalence Up in Celiac Disease, IBD Patients - MPR http://t.co/xoavZaPe

Voraxaze Injection Now Available - MPR

empr.com — “Voraxaze Injection Now Available - MPR” View full resource at empr.com

Most Recently Shared on April 30, 2012 at 3:06 pm By:

Voraxaze Injection Now Available #BTG #methotrexate #oncology http://t.co/8qMcfs5E

Stendra Approved for Erectile Dysfunction - MPR

empr.com — “The FDA announced that it has approved Stendra (avanafil; Vivus Inc.) tablets for the treatment of erectile dysfunction.” View full resource at empr.com

Most Recently Shared on April 30, 2012 at 1:54 pm By:

Stendra Approved for Erectile Dysfunction #urologist #pharmacist #ED http://t.co/V6vwnKR7